MedTrace Logo

Patient Controlled Administration of Liquid Acetaminophen

NCT06498713 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-10-29

No results posted yet for this study

Summary

This is a proof of concept pilot study investigating the feasibility and acceptability of patient controlled oral medication administration, using the commonly used and low risk medication in the hospital, oral acetaminophen.

Conditions

  • Pain
  • Pain, Postoperative

Interventions

DRUG

Acetaminophen 650 mg Oral Tablet

650 mg pills

DRUG

Acetaminophen 650mg Liquid

650 mg liquid

DEVICE

CADD pump

Primed and programmed to delivery 650 mg liquid acetaminophen into a medication cup every 4 hours as needed.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Jinlei Li, MD, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-19
Primary Completion
2025-12-31
Completion
2025-12-31
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06498713 on ClinicalTrials.gov